September 10, 2026

nitrosamine impurities

Nitrosamine Impurities in APIs: Causes, Risks & FDA Guidelines

In 2018, regulators pulled valsartan tablets off shelves worldwide after finding trace amounts of a chemical called NDMA inside the active ingredient. Ranitidine and metformin followed a similar path over the next two years. The common thread was a class of compounds known as nitrosamines, and the fallout changed how the entire industry looks at […]

Nitrosamine Impurities in APIs: Causes, Risks & FDA Guidelines Read More »

Scroll to Top
Please feel free to contact us, we will get back to you within 24 hours!